Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study

@inproceedings{Vrieling2011Serum2D,
  title={Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study},
  author={Alina Vrieling and Rebecca Hein and Sascha Abbas and Andreas Schneeweiss and Dieter Flesch-Janys and Jenny Chang-Claude},
  booktitle={Breast Cancer Research},
  year={2011}
}
Vitamin D has been postulated to be involved in cancer prognosis. Thus far, only two studies reported on its association with recurrence and survival after breast cancer diagnosis yielding inconsistent results. Therefore, the aim of our study was to assess the effect of post-diagnostic serum 25-hydroxyvitamin D [25(OH)D] concentrations on overall survival and distant disease-free survival. We conducted a prospective cohort study in Germany including 1,295 incident postmenopausal breast cancer… CONTINUE READING